{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:21:58Z","timestamp":1774030918745,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11095-014-1513-1","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T20:24:55Z","timestamp":1412108695000},"page":"1017-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Glucose-Lowering Potential of Exenatide Delivered Orally via Goblet Cell- Targeting Nanoparticles"],"prefix":"10.1007","volume":"32","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongcai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"1513_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2008.01.015","volume":"356","author":"BR Gedulin","year":"2008","unstructured":"Gedulin BR, Smith PA, Jodka CM, Chen K, Bhavsar S, Nielsen LL, et al. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration. Int J Pharm. 2008;356:231\u20138.","journal-title":"Int J Pharm"},{"key":"1513_CR2","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","volume":"267","author":"J Eng","year":"1992","unstructured":"Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992;267:7402\u20135.","journal-title":"J Biol Chem"},{"key":"1513_CR3","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","volume":"268","author":"R Goke","year":"1993","unstructured":"Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, et al. Exendin-4 is a high potency agonist and truncated exendin-(9\u201339)-amide an antagonist at the glucagon-like peptide 1-(7\u201336)-amide receptor of insulin-secreting beta-cells. J Biol Chem. 1993;268:19650\u20135.","journal-title":"J Biol Chem"},{"key":"1513_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","volume":"19","author":"JH Hamman","year":"2005","unstructured":"Hamman JH, Enslin GM, Kotze AF. Oral delivery of peptide drugs: barriers and developments. BioDrugs. 2005;19:165\u201377.","journal-title":"BioDrugs"},{"key":"1513_CR5","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","volume":"33","author":"Y Jin","year":"2012","unstructured":"Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials. 2012;33:1573\u201382.","journal-title":"Biomaterials"},{"key":"1513_CR6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/03639049809089942","volume":"24","author":"O Felt","year":"1998","unstructured":"Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998;24:979\u201393.","journal-title":"Drug Dev Ind Pharm"},{"key":"1513_CR7","doi-asserted-by":"crossref","unstructured":"Zhao J, Fan X, Zhang Q, Sun F, Li X, Xiong C, Zhang C, Fan H. Chitosan-plasmid DNA nanoparticles encoding small hairpin RNA targeting MMP-3 and \u221213 to inhibit the expression of dedifferentiation related genes in expanded chondrocytes. J Biomed Mater Res A. 2013.","DOI":"10.1002\/jbm.a.34711"},{"key":"1513_CR8","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","volume":"31","author":"K Sonaje","year":"2010","unstructured":"Sonaje K, Lin K-J, Wey S-P, Lin C-K, Yeh T-H, Nguyen H-N, et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-Responsive nanoparticles vs. subcutaneous injection. Biomaterials. 2010;31:6849\u201358.","journal-title":"Biomaterials"},{"key":"1513_CR9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.progpolymsci.2011.02.001","volume":"36","author":"M Dash","year":"2011","unstructured":"Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan\u2014A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36:981\u20131014.","journal-title":"Prog Polym Sci"},{"key":"1513_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0168-3659(93)90080-O","volume":"25","author":"S Shiraishi","year":"1993","unstructured":"Shiraishi S, Imai T, Otagiri M. Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo\/in vitro evaluation. J Control Release. 1993;25:217\u201325.","journal-title":"J Control Release"},{"key":"1513_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2008.09.091","volume":"133","author":"C-H Jin","year":"2009","unstructured":"Jin C-H, Chae SY, Son S, Kim TH, Um KA, Youn YS, et al. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db\/db mice. J Control Release. 2009;133:172\u20137.","journal-title":"J Control Release"},{"key":"1513_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/nnm.09.110","volume":"5","author":"E Roger","year":"2010","unstructured":"Roger E, Lagarce F, Garcion E, Benoit J-P. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (London, U K). 2010;5:287\u2013306.","journal-title":"Nanomedicine (London, U K)"},{"key":"1513_CR13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jbiotec.2008.01.021","volume":"135","author":"SK Kang","year":"2008","unstructured":"Kang SK, Woo JH, Kim MK, Woo SS, Choi JH, Lee HG, et al. Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells. J Biotechnol. 2008;135:210\u20136.","journal-title":"J Biotechnol"},{"key":"1513_CR14","doi-asserted-by":"crossref","first-page":"e57136","DOI":"10.1371\/journal.pone.0057136","volume":"8","author":"V Gupta","year":"2013","unstructured":"Gupta V, Doshi N, Mitragotri S. Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system. PLoS One. 2013;8:e57136.","journal-title":"PLoS One"},{"key":"1513_CR15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00125-002-0828-3","volume":"45","author":"Q Wangand","year":"2002","unstructured":"Wangand Q, Brubaker PL. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db\/db mice. Diabetologia. 2002;45:1263\u201373.","journal-title":"Diabetologia"},{"key":"1513_CR16","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","volume":"32","author":"HN Nguyen","year":"2011","unstructured":"Nguyen HN, Wey SP, Juang JH, Sonaje K, Ho YC, Chuang EY, et al. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo. Biomaterials. 2011;32:2673\u201382.","journal-title":"Biomaterials"},{"key":"1513_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6","volume":"89","author":"C Hilgendorf","year":"2000","unstructured":"Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P. Caco-2 versus Caco-2\/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci. 2000;89:63\u201375.","journal-title":"J Pharm Sci"},{"key":"1513_CR18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1019854327540","volume":"19","author":"I Behrens","year":"2002","unstructured":"Behrens I, Pena AI, Alonso MJ, Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res. 2002;19:1185\u201393.","journal-title":"Pharm Res"},{"key":"1513_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0928-0987(99)00032-9","volume":"8","author":"NG Schipper","year":"1999","unstructured":"Schipper NG, Varum KM, Stenberg P, Ocklind G, Lennernas H, Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs. 3: influence of mucus on absorption enhancement. Eur J Pharm Sci. 1999;8:335\u201343.","journal-title":"Eur J Pharm Sci"},{"key":"1513_CR20","first-page":"438","volume":"2013","author":"NC Deliolanisand","year":"2013","unstructured":"Deliolanisand NC, Ntziachristos V. Fluorescence molecular tomography of brain tumors in mice. Cold Spring Harb Protocol. 2013;2013:438\u201343.","journal-title":"Cold Spring Harb Protocol"},{"key":"1513_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2011.03.014","volume":"152","author":"Y Xiang","year":"2011","unstructured":"Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Control Release. 2011;152:402\u201310.","journal-title":"J Control Release"},{"key":"1513_CR22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00467-009-1435-z","volume":"25","author":"B Gallwitz","year":"2010","unstructured":"Gallwitz B. The evolving place of incretin-based therapies in type 2 diabetes. Pediatr Nephrol. 2010;25:1207\u201317.","journal-title":"Pediatr Nephrol"},{"key":"1513_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","volume":"117","author":"LL Nielsen","year":"2004","unstructured":"Nielsen LL, Young AA, Parkes DG. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regul Pept. 2004;117:77\u201388.","journal-title":"Regul Pept"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-014-1513-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1513-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:52:00Z","timestamp":1650286320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-014-1513-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s11095-014-1513-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}